Euthyroid Sick Syndrome in Patients With COVID-19
- PMID: 33117282
- PMCID: PMC7575767
- DOI: 10.3389/fendo.2020.566439
Euthyroid Sick Syndrome in Patients With COVID-19
Abstract
Background: Coronavirus disease 2019 (COVID-19) has been shown to affect almost every organ throughout the body. However, it is not clear whether the thyroid gland is impaired in COVID-19 patients. Euthyroid sick syndrome (ESS) is usually associated with the disease severity and deterioration prognosis in critical illness. In this study, the thyroid function of COVID-19 patients was assessed and factors associated with outcomes were analyzed to determine the potential predictive value of ESS.
Methods: Clinical and laboratory data of COVID-19 patients with or without ESS in Changsha, China, were collected and analyzed on admission. Kaplan-Meier curve and cox regression model were utilized to determine the correlation between ESS and the endpoints. Subsequently, a receiver operating characteristic (ROC) curve was plotted to evaluate the predictive performances of FT3 and C-reactive protein (CRP) in the disease severity.
Results: Forty-one (27.52%) cases of COVID-19 patients diagnosed with ESS. ESS patients had higher proportions of fever, shortness of breath, hypertension, diabetes, and severe events than those of non-ESS patients. The levels of erythrocyte sedimentation rate and C-reactive protein, and the positive rate of procalcitonin were significantly higher, whereas the lymphocyte count was apparently lower in ESS patients than in non-ESS patients. The regression analysis showed that ESS was significantly associated with the disease severity of COVID-19 (HR = 2.515, 95% CI: 1.050-6.026, P = 0.039). The areas under the curve (AUCs) for predicting the severe disease were [0.809 (95% CI 0.727-0.892), P < 0.001] and [0.792 (95% CI 0.689-0.895), P < 0.001] for FT3 and CRP, respectively.
Conclusion: ESS was significantly associated with the disease severity and inflammatory parameters in COVID-19 patients.
Keywords: C-reactive protein; Coronavirus Disease 2019 (COVID-19); disease severity; euthyroid sick syndrome; thyroid function.
Copyright © 2020 Zou, Wu, Zhang, Wang, Zhang, Yu, Wu, Dong, Wu, Wu and Zhong.
Figures
Comment in
-
Commentary: Euthyroid Sick Syndrome in Patients With COVID-19.Front Endocrinol (Lausanne). 2021 Feb 10;12:633097. doi: 10.3389/fendo.2021.633097. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33688850 Free PMC article. No abstract available.
Similar articles
-
Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.Front Endocrinol (Lausanne). 2020 Sep 24;11:571037. doi: 10.3389/fendo.2020.571037. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33071977 Free PMC article. Clinical Trial.
-
Thyroid dysfunction in the wake of Omicron: understanding its role in COVID-19 severity and mortality.Front Endocrinol (Lausanne). 2024 Jul 16;15:1412320. doi: 10.3389/fendo.2024.1412320. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39081794 Free PMC article.
-
A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.Med Sci Monit. 2020 Sep 11;26:e926393. doi: 10.12659/MSM.926393. Med Sci Monit. 2020. PMID: 32914767 Free PMC article.
-
Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review.Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1133-1142. doi: 10.1016/j.dsx.2020.07.005. Epub 2020 Jul 8. Diabetes Metab Syndr. 2020. PMID: 32663789 Free PMC article.
-
Survival in pediatric patients with cancer during the COVID-19 pandemic: scoping systematic review.Bol Med Hosp Infant Mex. 2020;77(5):234-241. doi: 10.24875/BMHIM.20000174. Bol Med Hosp Infant Mex. 2020. PMID: 33064683 English.
Cited by
-
The prognostic utility of serum thyrotropin in hospitalized Covid-19 patients: statistical and machine learning approaches.Endocrine. 2023 Apr;80(1):86-92. doi: 10.1007/s12020-022-03264-9. Epub 2022 Nov 29. Endocrine. 2023. PMID: 36445619 Free PMC article.
-
Potential relationships between COVID-19 and the thyroid gland: an update.J Int Med Res. 2022 Feb;50(2):3000605221082898. doi: 10.1177/03000605221082898. J Int Med Res. 2022. PMID: 35226548 Free PMC article. Review.
-
Nonthyroidal illness syndrome (NTIS) in severe COVID-19 patients: role of T3 on the Na/K pump gene expression and on hydroelectrolytic equilibrium.J Transl Med. 2021 Dec 3;19(1):491. doi: 10.1186/s12967-021-03163-z. J Transl Med. 2021. PMID: 34861865 Free PMC article.
-
Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry.Int J Infect Dis. 2022 Mar;116:319-327. doi: 10.1016/j.ijid.2022.01.016. Epub 2022 Jan 19. Int J Infect Dis. 2022. PMID: 35065257 Free PMC article.
-
Transient low T3 syndrome in patients with COVID-19: a new window for prediction of disease severity.Front Endocrinol (Lausanne). 2023 Jul 13;14:1154007. doi: 10.3389/fendo.2023.1154007. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37522120 Free PMC article.
References
-
- World Health Organization Novel Coronavirus (2019-nCoV) situation reports. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio... (Accessed Assessed on Augest 28th, 2020).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous